These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 20560001)

  • 1. Insights into human beta-cardiac myosin function from single molecule and single cell studies.
    Sivaramakrishnan S; Ashley E; Leinwand L; Spudich JA
    J Cardiovasc Transl Res; 2009 Dec; 2(4):426-40. PubMed ID: 20560001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myosin motor domains carrying mutations implicated in early or late onset hypertrophic cardiomyopathy have similar properties.
    Vera CD; Johnson CA; Walklate J; Adhikari A; Svicevic M; Mijailovich SM; Combs AC; Langer SJ; Ruppel KM; Spudich JA; Geeves MA; Leinwand LA
    J Biol Chem; 2019 Nov; 294(46):17451-17462. PubMed ID: 31582565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertrophic cardiomyopathy β-cardiac myosin mutation (P710R) leads to hypercontractility by disrupting super relaxed state.
    Vander Roest AS; Liu C; Morck MM; Kooiker KB; Jung G; Song D; Dawood A; Jhingran A; Pardon G; Ranjbarvaziri S; Fajardo G; Zhao M; Campbell KS; Pruitt BL; Spudich JA; Ruppel KM; Bernstein D
    Proc Natl Acad Sci U S A; 2021 Jun; 118(24):. PubMed ID: 34117120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of familial hypertrophic cardiomyopathy-linked mutations in the NH2 terminus of the RLC on β-myosin cross-bridge mechanics.
    Farman GP; Muthu P; Kazmierczak K; Szczesna-Cordary D; Moore JR
    J Appl Physiol (1985); 2014 Dec; 117(12):1471-7. PubMed ID: 25324513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-intrinsic functional effects of the α-cardiac myosin Arg-403-Gln mutation in familial hypertrophic cardiomyopathy.
    Chuan P; Sivaramakrishnan S; Ashley EA; Spudich JA
    Biophys J; 2012 Jun; 102(12):2782-90. PubMed ID: 22735528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early-Onset Hypertrophic Cardiomyopathy Mutations Significantly Increase the Velocity, Force, and Actin-Activated ATPase Activity of Human β-Cardiac Myosin.
    Adhikari AS; Kooiker KB; Sarkar SS; Liu C; Bernstein D; Spudich JA; Ruppel KM
    Cell Rep; 2016 Dec; 17(11):2857-2864. PubMed ID: 27974200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac and skeletal muscle expression of mutant β-myosin heavy chains, degree of functional impairment and phenotypic heterogeneity in hypertrophic cardiomyopathy.
    Di Domenico M; Casadonte R; Ricci P; Santini M; Frati G; Rizzo A; Carratelli CR; Lamberti M; Parrotta E; Quaresima B; Faniello CM; Costanzo F; Cuda G
    J Cell Physiol; 2012 Oct; 227(10):3471-6. PubMed ID: 22213221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in MYH7 reduce the force generating capacity of sarcomeres in human familial hypertrophic cardiomyopathy.
    Witjas-Paalberends ER; Piroddi N; Stam K; van Dijk SJ; Oliviera VS; Ferrara C; Scellini B; Hazebroek M; ten Cate FJ; van Slegtenhorst M; dos Remedios C; Niessen HW; Tesi C; Stienen GJ; Heymans S; Michels M; Poggesi C; van der Velden J
    Cardiovasc Res; 2013 Aug; 99(3):432-41. PubMed ID: 23674513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium-independent negative inotropy by beta-myosin heavy chain gene transfer in cardiac myocytes.
    Herron TJ; Vandenboom R; Fomicheva E; Mundada L; Edwards T; Metzger JM
    Circ Res; 2007 Apr; 100(8):1182-90. PubMed ID: 17363698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertrophic cardiomyopathy R403Q mutation in rabbit β-myosin reduces contractile function at the molecular and myofibrillar levels.
    Lowey S; Bretton V; Joel PB; Trybus KM; Gulick J; Robbins J; Kalganov A; Cornachione AS; Rassier DE
    Proc Natl Acad Sci U S A; 2018 Oct; 115(44):11238-11243. PubMed ID: 30322937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three perspectives on the molecular basis of hypercontractility caused by hypertrophic cardiomyopathy mutations.
    Spudich JA
    Pflugers Arch; 2019 May; 471(5):701-717. PubMed ID: 30767072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The familial hypertrophic cardiomyopathy-associated myosin mutation R403Q accelerates tension generation and relaxation of human cardiac myofibrils.
    Belus A; Piroddi N; Scellini B; Tesi C; D'Amati G; Girolami F; Yacoub M; Cecchi F; Olivotto I; Poggesi C
    J Physiol; 2008 Aug; 586(15):3639-44. PubMed ID: 18565996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype phenotype correlations of cardiac beta-myosin heavy chain mutations in Indian patients with hypertrophic and dilated cardiomyopathy.
    Rai TS; Ahmad S; Bahl A; Ahuja M; Ahluwalia TS; Singh B; Talwar KK; Khullar M
    Mol Cell Biochem; 2009 Jan; 321(1-2):189-96. PubMed ID: 18953637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial hypertrophic cardiomyopathy: functional effects of myosin mutation R723G in cardiomyocytes.
    Kraft T; Witjas-Paalberends ER; Boontje NM; Tripathi S; Brandis A; Montag J; Hodgkinson JL; Francino A; Navarro-Lopez F; Brenner B; Stienen GJ; van der Velden J
    J Mol Cell Cardiol; 2013 Apr; 57():13-22. PubMed ID: 23318932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered force generation and cell-to-cell contractile imbalance in hypertrophic cardiomyopathy.
    Kraft T; Montag J
    Pflugers Arch; 2019 May; 471(5):719-733. PubMed ID: 30740621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy.
    Olsson MC; Palmer BM; Stauffer BL; Leinwand LA; Moore RL
    Circ Res; 2004 Feb; 94(2):201-7. PubMed ID: 14670849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of Phenotypic Differences by Cardiovascular Magnetic Resonance Imaging in MYH7 (β-Myosin Heavy Chain)- Versus MYBPC3 (Myosin-Binding Protein C)-Related Hypertrophic Cardiomyopathy.
    Weissler-Snir A; Hindieh W; Gruner C; Fourey D; Appelbaum E; Rowin E; Care M; Lesser JR; Haas TS; Udelson JE; Manning WJ; Olivotto I; Tomberli B; Maron BJ; Maron MS; Crean AM; Rakowski H; Chan RH
    Circ Cardiovasc Imaging; 2017 Feb; 10(2):. PubMed ID: 28193612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac myosin binding protein-C phosphorylation in a {beta}-myosin heavy chain background.
    Sadayappan S; Gulick J; Klevitsky R; Lorenz JN; Sargent M; Molkentin JD; Robbins J
    Circulation; 2009 Mar; 119(9):1253-62. PubMed ID: 19237661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hypertrophic and dilated cardiomyopathy mutations on power output by human β-cardiac myosin.
    Spudich JA; Aksel T; Bartholomew SR; Nag S; Kawana M; Yu EC; Sarkar SS; Sung J; Sommese RF; Sutton S; Cho C; Adhikari AS; Taylor R; Liu C; Trivedi D; Ruppel KM
    J Exp Biol; 2016 Jan; 219(Pt 2):161-7. PubMed ID: 26792326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a myosin regulatory light chain mutation K104E on actin-myosin interactions.
    Duggal D; Nagwekar J; Rich R; Huang W; Midde K; Fudala R; Das H; Gryczynski I; Szczesna-Cordary D; Borejdo J
    Am J Physiol Heart Circ Physiol; 2015 May; 308(10):H1248-57. PubMed ID: 25770245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.